Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verve Therapeutics Inc
(NQ:
VERV
)
4.940
+0.100 (+2.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verve Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
November 06, 2023
Roku vaulted 50% to become Ark Innovation's top holding.
Via
Investor's Business Daily
Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On
November 01, 2023
Are you looking to invest in disrupting stocks like Cathie Woods? Here are three stocks Cathie Wood is betting millions on.
Via
InvestorPlace
Why Beam and Verve Therapeutics Shares Soared While Eli Lilly Soured Today
October 31, 2023
Lilly is putting its money where its mouth is with its purchase of cutting-edge medical technology.
Via
The Motley Fool
Verve Stock Soars On $250 Million Eli Lilly Deal
October 31, 2023
Eli Lilly now owns the opt-in rights to three more of Verve's cardiovascular drugs.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 31, 2023
Via
Benzinga
1 Cathie Wood Stock That Could Go Parabolic Soon
August 31, 2023
This next-gen biotech stock is barreling toward a major catalyst.
Via
The Motley Fool
Expert Ratings for Verve Therapeutics
August 29, 2023
Via
Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
October 31, 2023
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Beam Therapeutics Stock Is Getting Bought Today
October 31, 2023
Beam Therapeutics Inc (NASDAQ: BEAM) shares are trading higher Tuesday after Eli Lilly And Co (NYSE: LLY) agreed to acquire certain rights under Beam's
Via
Benzinga
Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3
October 31, 2023
Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics
From
Verve Therapeutics
Via
GlobeNewswire
With 1 Roadblock Down, Is Verve Therapeutics a Buy Now?
October 30, 2023
It takes more than starting a clinical trial to make for a good investment.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
Via
Benzinga
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia
October 23, 2023
From
Verve Therapeutics
Via
GlobeNewswire
2 Incredible Growth Stocks Near 52-Week Lows to Buy Now
October 10, 2023
These two high-tech bio companies may be too cheap to ignore right now.
Via
The Motley Fool
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...
Via
Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association’s Scientific Sessions 2023
September 26, 2023
Company to hold investor event in conjunction with data presentation on November 12, 2023
From
Verve Therapeutics
Via
GlobeNewswire
Verve Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
September 21, 2023
From
Verve Therapeutics
Via
GlobeNewswire
Verve Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer
September 18, 2023
From
Verve Therapeutics
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
August 29, 2023
On Tuesday, 99 stocks hit new 52-week lows.
Via
Benzinga
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
August 10, 2023
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.
Via
Benzinga
Topics
ETFs
Economy
Exposures
Interest Rates
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Verve Therapeutics
Via
GlobeNewswire
Verve Therapeutics to Present at the Canaccord 43rd Annual Growth Conference
August 03, 2023
From
Verve Therapeutics
Via
GlobeNewswire
Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD
July 21, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) is not even as good as Danaher Corporation (NYSE: DHR).
Via
Benzinga
Cathie Wood Is Buying This Biotech, but Here's Why I'm Not
July 13, 2023
The risks are too high, and it'll take a while for them to be addressed.
Via
The Motley Fool
Cathie Wood Buys More Meta Shares As Mark Zuckerberg Goes All-In On Twitter Rivalry
July 07, 2023
Via
Benzinga
Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday
July 03, 2023
Via
Benzinga
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest
June 30, 2023
Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June.
Via
MarketBeat
5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More
June 15, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.